Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2009 Publisher: Sanofi-aventis, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
UbretidTM.
Pharmaceutical Form |
---|
Tablets. |
Active ingredient Distigmine bromide 5mg.
Active Ingredient | Description | |
---|---|---|
Distigmine |
|
List of Excipients |
---|
Lactose |
Blisters of 20μm aluminium foil and 250μm UPVC/PVdC opaque white film containing 30 tablets.
Sanofi-aventis, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
PL 04425/0617
7 February 2009
Drug | Countries | |
---|---|---|
UBRETID | Austria, Estonia, Hong Kong, Japan, Netherlands, Poland, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.